{"assets":[{"id":5,"required":0,"title":{"text":"Adding convenience with a higher strength option"}},{"id":6,"required":0,"img":{"url":"https://ad.adsrvr.org/a0vvs99/703bln6/ggg3qyyh_main_0_1200x627.jpg","w":1200,"h":627,"ext":{"type":3}}},{"id":8,"required":0,"data":{"value":"Learn More","ext":{"type":12}}},{"id":10,"required":0,"data":{"value":"Labetalol","ext":{"type":1}}},{"id":11,"required":0,"data":{"value":"New strength, same trusted Labetalol: 400 mg now here","ext":{"type":2}}}],"imptrackers":["https://vam-bid.adsrvr.org/bid/feedback/kargo?t=1&iid=a355c404-2ae6-43b5-a783-f4af7bb6dd0f&crid=ggg3qyyh&wp=0.921965&aid=d21df95f-5ca5-47d9-856d-6d03cbf3f15f&wpc=USD&sfe=1b4ca350&puid=93ee0501-78a7-2fb1-e04d-d418ffff1738&bdc=131&tdid=958715ed-0720-40ce-b70a-b3047487027a&uidd=RqgyPy9sbFaeiBOA2qoP6HTGQk9YcqNa-37n1o9nrsYdh3oG&pid=a0vvs99&ag=lqjj6qj&adv=703bln6&sig=1KTTYZ0DKu7eMt9qe7fZhQDDWO2U_e7oZR-UoutuoP0A.&bp=1.78253614030102&cf=9443358&fq=0&td_s=nypost.com&rcats=&mste=&mfld=3&mssi=&mfsi=&uhow=91&agsa=&rgz=02151&svbttd=1&dt=Mobile&osf=Android&os=Android100&br=Chrome&rlangs=en&mlang=&svpid=137&did=&rcxt=MobileOptimizedWeb&lat=42.412500&lon=-71.003400&tmpc=5.550000000000011&daid=&vp=0&osi=&osv=&bffi=41&mk=Android&mdl=Generic%20Android%20Mobile&testid=iavc1%20&car=509&npt=2&cc=1~KLUv_WNa1XJFegBVCgDjk0s9A3neQB5vAM8buOsZsOsZsGoVuGPREEDEEsjzBPLYPZrTNYcUHCgToC0OURCupDA_arQggS-slZ2AlbWyE4DiB6BiDtiZA-yYA6zMAVBcIev-AXSukMz9A4awA3LMAvBYAVB8AEi-AHlttp1MQp3AAFcfAMsSL9E1deI3E5qT6Dp7gYJAgCGiBAjZQbsoF7ilyW9B8m3dfTdCtnZ6C0q7lcRvBelt5ehpoWK1QPm0MD3QgiQgiBYiAUG08rTM6PaTmsKntYMDh2QS9mUJ8t77rDQ-y-qzoPSErPuxFHksKB4riXfzaAFz9IRZ7v-pan2QWN-dHc2f0ufa0tajXtRpLn3gM9P7eZ6to41zy8HW7Tcb7Tfk8mIFDWikxgYZUjy6FAhLk8FSlhV1PpYBOAb81pZ_YWiovaYL9ovkVAHxB_qOnJSPfQg.&dur=1~KLUv_WMFoCgkJgAFAwCEBEcKBzE2dHVtMHUiPAiN3I-4LFV2UGd1TXRtVXlqU0hqRk92WWxaNlFWcDV4Q0cvWG0zc01xNjMrNUt0aXPxMjgDQAFNa4KMPwb8ylwV7Aun6DePN9Os9NXMf_jKlhE.&durs=MtELsY&crrelr=&fpa=517&pcm=3&vc=12&said=cf6cd9d1-0479-43e3-bcc1-2a1f03c78e7e&ict=CellularNetwork4G&auct=1&im=1&mc=00062047-b41c-47ff-86ff-a2d19303642e&idl=XY3007jYAvhaYZyvMGlFqCs9Pob0ZZ8jQb3Rdwp1JGm7lMzY0&ev=7mEkhPhQOBNcOKvRc59rvuJXerjIr8UYzNX7wn5Ix7w.&rsv=0.000641617842800255&abr=3b0df90e-71ac-4da0-b837-c43dccb08be8&tail=1"],"link":{"clicktrackers":[],"url":"https://insight.adsrvr.org/track/clk?imp=a355c404-2ae6-43b5-a783-f4af7bb6dd0f&ag=lqjj6qj&sfe=1b4ca350&sig=OnzSbxuiQKMaUBrYV0dCJA8NeX44u5h_VWHj8mGSt4U.&crid=ggg3qyyh&cf=9443358&fq=0&t=1&td_s=nypost.com&rcats=&mste=&mfld=3&mssi=&mfsi=&sv=kargo&uhow=91&agsa=&wp=0.921965&rgz=02151&dt=Mobile&osf=Android&os=Android100&br=Chrome&svpid=137&rlangs=en&mlang=&did=&rcxt=MobileOptimizedWeb&tmpc=5.550000000000011&vrtd=&osi=&osv=&daid=&dnr=0&vpb=&crrelr=&npt=2&cc=2~KLUv_WMdqREM3gMtGACDZIS4XFtUbk1Uji0qx0UBg5fLDctaIDJZZCzJcxbJaQDiScKKEJQW-lcRKlfdWxEqtwRHeOjQy-x4RYUSFUoJbByOSWf8KJqhSAaVNyPO3FxeY3cKJYSDTQ8SJKlXqNn_h03h4TAM7Wgl6yLb-dxLbNdVy13boj_rYiczL8simdWun1sD9-bXFxOOe64hHkzuvKq9Ud6SHfvr3dNgXUckL7mE_-zR_qFducC23Dj6VbbTaNozsuo1eNShRY_JWhcTo0a3wi4znpBn7swgV2cj-X0J1SafXMzrMRnffdFmEpNQn560ooV5XcVquSbq8DAzfucFDBbDjr0Z-kMKweqYCvSVdO8qnZXG6LbZA4N5P5IKxGEzrtF5P4NcsTTbf807komfncF71Cuv9qZAZ9CI3Z6Z6UrszowZnZW9WZUKzaMx9J51-nHKm-VNZDBMaHtFp_Kui7f0deBezbde2-T0C7YitNVL6ZhzBIuFKKqsYAT4xnW9X8c3XvMz_Me6rIt5vs973u6DRc-hJ4s-SJVovE-9MGeHJziCftyQ-mRiwsxGt2XBtf3aaU2Fdxw4Nhvq3Gf4NgPJiyAvPawW3HMc1_FXAvONx3Svi3X89p8YCpWm3G6nc5KNChGvBkZigBIypzaTOXVW8SD80dLAFEsqmLy9LB0QIRE7MxX_87_zM9zbur6_ad1f91od3jFZeV7FYmE9SPyARSp3EU-rEKJO9b5DaNqDPGDNrXsmBYxBKSssuDgzii8w2CpBkV8M3K2DL6WBzaXbIucTsXEHuhvpDIwZBep4h4n9Q_KPowYnO-O7SnGnYqBQ1lL_oazHa7cy2E6nkyA6o3KFPWKwK-7yNKWyRc6Q9Ri-fBynB4eOAfDWygAewoeQnyuYxoLxhH7N1psGZth0baNP-PlrXCXs6g8pJVOM9AFcOwjctKIJJNEU6v4tUbfrL0mJ1cos5O9r6mKFhJjJgv1RPIPVGajLdH4xa7vtgSJ4kEV2r4bQe9q9yESL6iRYUG8Y5LMUUndidSvZMg..&dur=1~KLUv_WMFoCgkJgAFAwCEBEcKBzE2dHVtMHUiPAiN3I-4LFV2UGd1TXRtVXlqU0hqRk92WWxaNlFWcDV4Q0cvWG0zc01xNjMrNUt0aXPxMjgDQAFNa4KMPwb8ylwV7Aun6DePN9Os9NXMf_jKlhE.&durs=MtELsY&bdc=131&uidd=RqgyPy9sbFaeiBOA2qoP6HTGQk9YcqNa-37n1o9nrsYdh3oG&idl=XY3007jYAvhaYZyvMGlFqCs9Pob0ZZ8jQb3Rdwp1JGm7lMzY0&mk=Android&mdl=Generic%20Android%20Mobile&testid=iavc1%20&car=509&fpa=517&pcm=3&ict=CellularNetwork4G&said=cf6cd9d1-0479-43e3-bcc1-2a1f03c78e7e&auct=1&tail=1&r=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27e4ab03-c17b-4268-912c-e45a5e8f8dd8&audience=consumer"},"native":{"assets":""}}
